Adverse Drug Reactions Journal
Published by Chinese Medical Journals Publishing House Co.Ltd
ISSN : 1008-5734
Abbreviation : Advers. Drug React. J.
Aims & Scope
Adverse Drug Reactions Journal" (Adverse Drug Reactions Journal) is an academic journal published at home and abroad under the supervision of the China Association for Science and Technology and sponsored by the Chinese Medical Association.
It was founded in 1999 and is a monthly publication.
ISSN 1008-5734.
The founder of the magazine, Cheng Jinghua, chief pharmacist, is the main advocate and initiator of China's adverse drug reaction monitoring work.
The current editor-in-chief Professor Wang Yuqin is a professor of clinical pharmacology at Capital Medical University, a member of the China Center Group and leader of the Clinical Safety Medication Group of the International Network for Rational Use of Drugs (INRUD) of the National Health and Family Planning Commission, and the Chinese Pharmacological Society Director and honorary chairman of the Professional Committee of Drug-Induced Diseases. "Journal of Adverse Drug Reactions" has a sound editorial committee.
Professor Chen Keji, academician of the Academy of Sciences, and Professor Gao Runlin, Zhou Honghao, and Zhong Nanshan, academicians of the Academy of Engineering, serve as consultants.
The editorial committee comes from 28 provinces, autonomous regions, municipalities directly under the Central Government (including Taiwan) and the United States, covering clinical medicine ( Cardiovascular, respiratory, digestive, kidney, nervous, mental, endocrine, rheumatic immunity, blood, infection, infection, tumor, allergy, dermatology, etc.), pharmacy (clinical pharmacy, clinical pharmacology, pharmacy, pharmacoeconomics and pharmaceutical management), clinical toxicology, epidemiology and statistics and other professional fields.
View Aims & ScopeMetrics & Ranking
Journal Rank
| Year | Value |
|---|---|
| 2024 | 26616 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 78 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.127 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q4 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.